136 related articles for article (PubMed ID: 8393333)
21. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis.
Lueke AJ; Meeusen JW; Donato LJ; Gray AV; Butterfield JH; Saenger AK
Clin Biochem; 2016 Sep; 49(13-14):979-82. PubMed ID: 26908217
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of cysteinyl leukotrienes by the isolated perfused rat kidney.
Fauler J; Wiemeyer A; Yoshizawa M; Schurek HJ; Frolich JC
Prostaglandins; 1991 Sep; 42(3):239-49. PubMed ID: 1664114
[TBL] [Abstract][Full Text] [Related]
23. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
[TBL] [Abstract][Full Text] [Related]
24. Recovery of leukotriene E4 from the urine of patients with airway obstruction.
Drazen JM; O'Brien J; Sparrow D; Weiss ST; Martins MA; Israel E; Fanta CH
Am Rev Respir Dis; 1992 Jul; 146(1):104-8. PubMed ID: 1320817
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney.
Moore KP; Wood J; Gove C; Tan KC; Eason J; Taylor GW; Williams R
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():697-700. PubMed ID: 1847571
[No Abstract] [Full Text] [Related]
26. Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes.
Stene DO; Murphy RC
J Biol Chem; 1988 Feb; 263(6):2773-8. PubMed ID: 2830262
[TBL] [Abstract][Full Text] [Related]
27. Significance of production of peptide leukotrienes in murine traumatic shock.
Craft DV; Lefer DJ; Hock CE; Lefer AM
Am J Physiol; 1986 Jul; 251(1 Pt 2):H80-5. PubMed ID: 3014907
[TBL] [Abstract][Full Text] [Related]
28. Comparison of urinary leukotriene E4 and 16-carboxytetranordihydro leukotriene E4 excretion in allergic asthmatics after inhaled antigen.
Tagari P; Rasmussen JB; Delorme D; Girard Y; Eriksson LO; Charleson S; Ford-Hutchinson AW
Eicosanoids; 1990; 3(2):75-80. PubMed ID: 2169776
[TBL] [Abstract][Full Text] [Related]
29. Sputum cysteinyl-leukotriene levels correlate with the severity of pulmonary disease in children with cystic fibrosis.
Spencer DA; Sampson AP; Green CP; Costello JF; Piper PJ; Price JF
Pediatr Pulmonol; 1992 Feb; 12(2):90-4. PubMed ID: 1315018
[TBL] [Abstract][Full Text] [Related]
30. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis.
Taylor GW; Taylor I; Black P; Maltby NH; Turner N; Fuller RW; Dollery CT
Lancet; 1989 Mar; 1(8638):584-8. PubMed ID: 2564113
[TBL] [Abstract][Full Text] [Related]
31. Enzymic preparation of dioxygen-18 labelled leukotriene E4 and its use in quantitative gas chromatography-mass spectrometry.
Tsikas D; Fauler J; Frölich JC
J Chromatogr; 1992 Feb; 574(2):181-7. PubMed ID: 1320043
[TBL] [Abstract][Full Text] [Related]
32. Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects.
Maclouf J; Antoine C; De Caterina R; Sicari R; Murphy RC; Patrignani P; Loizzo S; Patrono C
Am J Physiol; 1992 Jul; 263(1 Pt 2):H244-9. PubMed ID: 1322060
[TBL] [Abstract][Full Text] [Related]
33. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
Tagari P; Becker A; Brideau C; Frenette R; Sadl V; Thomas E; Vickers P; Ford-Hutchinson A
J Pharmacol Exp Ther; 1993 Apr; 265(1):416-25. PubMed ID: 8386242
[TBL] [Abstract][Full Text] [Related]
34. Enhanced urinary excretion of leukotriene E4 by patients with multiple trauma with or without adult respiratory distress syndrome.
Fauler J; Tsikas D; Holch M; Seekamp A; Nerlich ML; Sturm J; Frölich JC
Clin Sci (Lond); 1991 May; 80(5):497-504. PubMed ID: 1851691
[TBL] [Abstract][Full Text] [Related]
35. Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation.
Carry M; Korley V; Willerson JT; Weigelt L; Ford-Hutchinson AW; Tagari P
Circulation; 1992 Jan; 85(1):230-6. PubMed ID: 1309444
[TBL] [Abstract][Full Text] [Related]
36. Gas chromatographic-mass spectrometric determination of leukotriene E4 in human urine using deuterium-labelled leukotriene E4 standards.
Tsikas D; Fauler J; Gutzki FM; Röder T; Bestmann HJ; Frölich JC
J Chromatogr; 1993 Dec; 622(1):1-7. PubMed ID: 8120106
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
Wettstein M; Gerok W; Häussinger D
Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
[TBL] [Abstract][Full Text] [Related]
38. Cigarette smoking stimulates cysteinyl leukotriene production in man.
Fauler J; Frölich JC
Eur J Clin Invest; 1997 Jan; 27(1):43-7. PubMed ID: 9041376
[TBL] [Abstract][Full Text] [Related]
39. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W
Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116
[TBL] [Abstract][Full Text] [Related]
40. n-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo.
von Schacky C; Kiefl R; Jendraschak E; Kaminski WE
J Lab Clin Med; 1993 Feb; 121(2):302-9. PubMed ID: 8381847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
